Healthcare analysts Arthur Wong and Adam Dibe chat about some recent pharma developments – Amgen’s biosimilar on Humira, Big Pharma’s interest in biopharmaceutical company, Medivation, Inc., and an investor question on specialty pharma company Endo International PLC.